Quasar Alexander Announces Campaign for Mayor, Vows to “Fast Forward” South Fulton With a Plan to Empower Residents and Build Wealth

SOUTH FULTON, Ga., Aug. 04, 2025 (GLOBE NEWSWIRE) — Entrepreneur and community advocate Quasar Alexander has formally announced his candidacy for Mayor of South Fulton, promising a bold agenda to move the city forward–and to finally deliver solutions for families who, like his own, have done everything right but still face emergencies after crisis. Alexander's […]

Quasar Alexander Announces Campaign for Mayor, Vows to “Fast Forward” South Fulton With a Plan to Empower Residents and Build Wealth

Quasar Alexander Announces Campaign for Mayor, Vows to “Fast Forward” South Fulton With a Plan to Empower Residents and Build Wealth GlobeNewswire August 05, 2025 SOUTH FULTON, Ga., Aug. 04, 2025 (GLOBE NEWSWIRE) — Entrepreneur and community advocate Quasar Alexander has formally announced his candidacy for Mayor of South Fulton, promising a bold agenda to

2025 Report: “ProZenith Reviews and Complaints” Search Surge Mirrors Interest in Clean Energy Supplements

2025 Report: “ProZenith Reviews and Complaints” Search Surge Mirrors Interest in Clean Energy Supplements Increased search volume around clean-label metabolic supplements — including queries like “ProZenith complaints” — reflects a wider shift in how consumers are navigating stimulant-free wellness solutions in North America. GlobeNewswire August 05, 2025 Los Angeles, Aug. 04, 2025 (GLOBE NEWSWIRE) —

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

(NASDAQ:PRAX), BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be participating a virtual fireside chat hosted by Truist Securities analyst

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

Praxis Precision Medicines to Participate in Upcoming Fireside Chat GlobeNewswire August 05, 2025 BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza

Why XentaFlex Is Emerging as 2025’s Most Affordable, Simplest, and Most Effective Joint Pain Solution

Why XentaFlex Is Emerging as 2025's Most Affordable, Simplest, and Most Effective Joint Pain Solution More Americans Are Rethinking Collagen, Glucosamine, and Pills in 2025 as Public Curiosity Shifts Toward Ingredient-First Joint Hydration Formulas Like Simple Promises' XentaFlex GlobeNewswire August 05, 2025 Salt Lake City, Aug. 04, 2025 (GLOBE NEWSWIRE) — A growing number of

Lost Money on Replimune Group, Inc. (REPL)? Urged to Join Class Action Before September 22, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=159723&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Investor Alert: Deadline Approaching to Join Lockheed Martin Corporation (LMT) Class Action – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=159721&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Investors in iRobot Corporation (IRBT): Protect Your Rights – Contact Levi & Korsinsky Before September 5, 2025

NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=159722&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top